Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • FAST Login
  • Easy Setup
  • Find a Centre
  • SMART Portal
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
    • Cardiac T2* with FerriScan
    • HepaFat-Scan - MRI Measurement of Liver Fat
    • Bone Marrow R2-MRI
    • MRI Phantoms
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2012

ASX Announcements 2012

Date Document
21/12/2012 Newsletter-December 2012
21/12/2012 Fibrosis Update
15/11/2012 Results of Annual General Meeting
15/11/2012 AGM Presentation to Shareholders
07/11/2012 FerriScan gains ground with US Insurance Payers
31/10/2012 Appendix 4C - quarterly
23/10/2012 FerriScan contracted for two new Clinical Trials
18/10/2012 FDA requests a broader Indication for Use for Ferriscan
15/10/2012 Annual Report to shareholders
15/10/2012 Notice of Annual General Meeting Proxy Form
15/10/2012 Notice of Annual General Meeting/Proxy Form
28/09/2012 Full Year Statutory Accounts
31/08/2012 Preliminary Final Report
31/07/2012 Appendix 4C - quarterly
11/07/2012 FDA Submission for HepaFat Scan & update Liver Fibrosis Test
30/04/2012 Appendix 4C - quarterly
05/04/2012 Update on HepaFat Scan and Liver Fibrosis Test
19/03/2012 Company Secretary Appointment/Resignation
29/02/2012 Half Yearly Report and Accounts
31/01/2012 Appendix 4C - quarterly

 

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by ChooseDigital.com.au